Exhibitors Search
Lonza
Booth no.
P70
|
Exhibition
|
|KOREA LIFE SCIENCE |
|---|---|
|
Country
|
| Switzerland |
|
Address
|
|Muenchensteinerstrasse 38, 4002 Basel, Switzerland |
|
Tel
|
|+41-41-- |
|
Exhibits
|
| Biologics development and manufacturing services (CDMO), cell line development (CLD), process development, early development services (EDS), GMP drug substance and drug product manufacturing, CMC and regulatory support. |
|
Company Type
|
| CRO / CMO Company |
Exhibitor Information
Lonza is a world-leading CDMO dedicated to serving the healthcare industry.
Founded in Switzerland in 1897, Lonza partners with customers ranging from emerging biotechnology companies to global pharmaceutical organizations to transform scientific innovation into life-saving and life-enhancing therapies.
With more than 125 years of experience and a global network spanning over 30 sites worldwide, Lonza provides integrated solutions across the entire product lifecycle, from early development through commercial manufacturing.
Its capabilities include cell line development, process development, analytical and regulatory support, drug substance and drug product manufacturing, helping customers accelerate development, reduce risk, and successfully bring innovative medicines to patients around the world.
Founded in Switzerland in 1897, Lonza partners with customers ranging from emerging biotechnology companies to global pharmaceutical organizations to transform scientific innovation into life-saving and life-enhancing therapies.
With more than 125 years of experience and a global network spanning over 30 sites worldwide, Lonza provides integrated solutions across the entire product lifecycle, from early development through commercial manufacturing.
Its capabilities include cell line development, process development, analytical and regulatory support, drug substance and drug product manufacturing, helping customers accelerate development, reduce risk, and successfully bring innovative medicines to patients around the world.
Exhibit Description
Early Development Services (EDS)- Supporting early-stage programs through developability assessment and CMC de-risking to enable informed development decisions.
DNA-to-IND Programs - An integrated development solution combining cell line development, process development, analytical development, and CMC support to help accelerate progression toward IND submission.
Clinical & Commercial Manufacturing - Comprehensive drug substance and drug product manufacturing services from clinical supply to commercial production, supported by Lonza's global manufacturing network and regulatory expertise.
DNA-to-IND Programs - An integrated development solution combining cell line development, process development, analytical development, and CMC support to help accelerate progression toward IND submission.
Clinical & Commercial Manufacturing - Comprehensive drug substance and drug product manufacturing services from clinical supply to commercial production, supported by Lonza's global manufacturing network and regulatory expertise.
KYUNGYON EXHIBITION CORP.
